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Abstract
Background: There is a significant gap in the knowledge translation literature related to how research evidence actually
contributes to health care decision-making. Decisions around what care to provide at the population (rather than
individual) level are particularly complex, involving considerations such as feasibility, cost, and population needs in
addition to scientific evidence. One example of decision-making at this "population-policy" level involves what screening
questions and intervention guides to include on standardized provincial prenatal records. As mandatory medical
reporting forms, prenatal records are potentially powerful vehicles for promoting population-wide evidence-based care.
However, the extent to which Canadian prenatal records reflect best-practice recommendations for the assessment of
well-known risk factors such as maternal smoking and alcohol consumption varies markedly across Canadian provinces
and territories. The goal of this study is to better understand the interaction of contextual factors and research evidence
on decision-making at the population-policy level, by examining the processes by which provincial prenatal records are
reviewed and revised.
Methods: Guided by Dobrow et al.'s (2004) conceptual model for context-based evidence-based decision-making, this
study will use a multiple case study design with embedded units of analysis to examine contextual factors influencing the
prenatal record revision process in different Canadian provinces and territories. Data will be collected using multiple
methods to construct detailed case descriptions for each province/territory. Using qualitative data analysis techniques,
decision-making processes involving prenatal record content specifically related to maternal smoking and alcohol use will
be compared both within and across each case, to identify key contextual factors influencing the uptake and application
of research evidence by prenatal record review committees. All study participants will be required to give written
informed consent prior to participating in data collection.
Conclusion: This study will advance knowledge in the field of evidence-based decision-making by illustrating the
complex interaction of contextual factors and evidence on health policy decision-making by provincial-level committees.
By increasing the transparency of decision-making within provincial prenatal record committees, this study will help
inform more effective strategies for enhancing the integration of best-practice evidence into prenatal records.
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Background
Despite increasing emphasis on the production of high-
quality research evidence in health care, much is
unknown about how evidence is actually used in decision-
making [1]. Decisions around what care to provide at the
population (rather than individual) level are particularly
complex, involving considerations such as feasibility,
cost, population needs and political attractiveness in addi-
tion to scientific evidence [2-4]. As mandatory medical
reporting forms, provincial prenatal records are poten-
tially powerful vehicles for promoting best-practice rec-
ommendations. Decisions made by provincial-level
review committees about what screening questions and
intervention prompts to include on prenatal records are
vital, as these documents guide routine prenatal care and
have population-wide reach. The extent to which current
prenatal records reflect the evidence base around impor-
tant risk factors such as maternal smoking and alcohol use
varies markedly across Canadian provinces and territories
[5], begging the question of how research evidence pene-
trates the prenatal record revision process. Since the avail-
able research base for prenatal risk factors is presumably
the same for all prenatal record review committees,
marked differences in the content of provincial prenatal
records point to differences in the broader decision-mak-
ing environment within which these forms are developed
and updated. Decision-making related to provincial pre-
natal record content is particularly pertinent as pregnancy
and childbirth remain the most common reasons for hos-
pitalization among Canadian women [6]; these manda-
tory forms are widely used by health care providers across
a variety of disciplines; however the processes by which
research evidence is integrated into such provincial-level
health policy decisions remains poorly understood [7].
Aims
To gain an in-depth understanding of the influence of
contextual factors on evidence use by provincial/territo-
rial prenatal record review committees, this study will
focus on two specific exemplars: the uptake of research
evidence related to maternal smoking, and alcohol con-
sumption during pregnancy. The scientific evidence iden-
tifying smoking and alcohol use as risk factors for adverse
obstetrical outcomes is well-documented and long-stand-
ing [8,9] meriting closer examination of how and why
prenatal screening for these two factors varies among
provinces. Specific objectives of this study are to:
1) Describe and compare how provincial prenatal records
are reviewed and updated across selected Canadian prov-
inces;
2) Identify specific contextual factors in the decision-mak-
ing environment that impede or facilitate the use of
research evidence during the prenatal record revision
process, as well as alternative sources of evidence contrib-
uting to decision-making within provincial prenatal
record committees; and
3) Explore the relative impact of internal versus external
contextual factors on the integration of research evidence
in provincial practice policies such as the prenatal record.
Four main research questions underlie these study objec-
tives:
What are the processes and who are the actors involved in
developing and revising provincial prenatal records?
How are decisions made about the content of provincial
prenatal records related specifically to maternal smoking
and prenatal alcohol?
What key contextual factors influence the uptake of
research evidence during the prenatal record revision
process?
What other factors in the decision-making environment at
the provincial level may account for variations in the evi-
dence base of prenatal records across provinces?
Summary of the Literature
Canadian provincial prenatal records
Standardized provincial prenatal assessment forms are
universally used in most provinces and territories in Can-
ada to serve as a written health record which may be trans-
ferred from one part of the health care system to another
(e.g., obstetrician's office to hospital obstetrical unit) and
provide data for routine surveillance of perinatal risk fac-
tors. The government prenatal records for each province
and territory typically include a comprehensive health his-
tory form completed by health care providers at the first
prenatal visit, as well as additional forms for documenta-
tion of on-going prenatal care at each subsequent encoun-
ter. By providing health care practitioners with reminders
and prompts, provincial prenatal records outline the con-
tent of routine prenatal care and play a key role in guiding
health professionals in what to assess and how to inter-
vene with pregnant women. Physician reminders and
prompts have been identified as one of the most effective
mechanisms for transferring evidence into routine prac-
tice in preventative care [10]. As standardized assessment
tools that are part of regulated surveillance systems, pro-
vincial prenatal records are potentially influential con-
duits for population-wide dissemination of best-practice
recommendations [11]. Each province and territory in
Canada has its own unique prenatal record, except for
Yukon Territory (which uses British Columbia's prenatal
record forms); and New Brunswick (where prenatal
records are developed at the regional level). DecisionsBMC Health Services Research 2008, 8:266 http://www.biomedcentral.com/1472-6963/8/266
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about what to include and what to exclude in the way of
risk factors and prompts on the prenatal record forms are
typically made by a provincially-mandated multidiscipli-
nary committee [5]. Canadian provinces and territories
vary in the frequency that they review and update their
prenatal records, but in general these provincially-regu-
lated forms are formally revised and reprinted every few
years.
Despite the potential for manipulating prenatal records to
mandate evidence-based clinical care, literature examin-
ing and comparing the content and quality of Canadian
prenatal records is virtually non-existent. A recent exami-
nation of Canadian prenatal records for their content
related to maternal smoking found marked variation in
the application of available research evidence across prov-
inces [5]. In the published literature, one study was found
that compared national prenatal care clinical practice
guidelines from four countries including Canada,
although the Canadian documents surveyed (Healthy
Beginnings: Guidelines for Care during Pregnancy and
Childbirth [12] and The Canadian Guide to Clinical Pre-
ventative Health Care [13]) do not necessarily model the
content for the provincial and territorial prenatal records.
This comparison found little consistency either within or
across countries in terms of their recommendations for
routine prenatal care, and called for re-examination of the
evidence-base of the national prenatal care guidelines
[14]. Similarly, a survey of routine prenatal care guide-
lines in Australia found local protocols varied widely
across institutions and were not consistent with national
policies or research evidence. This study highlighted the
need to develop standardized prenatal care recommenda-
tions based on systematic reviews of the evidence [15].
Evidence-based decision-making
A central focus of the study of knowledge utilization in
health care is to better understand why available research
evidence is not readily adopted. Few studies, however,
have explored precisely how research evidence is evalu-
ated and integrated into provincial-level practice policies.
This specific area of inquiry is uniquely situated between
two more extensively-researched bodies of literature in
the field of evidence-based decision-making: 1) the devel-
opment and implementation of clinical practice guide-
lines (CPGs), and 2) evidence-based health policymaking.
The following text addresses each of these topics in further
detail.
Evidence-based CPGs are increasingly viewed as impor-
tant decision-making tools in the quest to improve the
quality and effectiveness of health care [16-18]. Growing
attention is being paid to the actual processes involved in
developing and maintaining the content of CPG's [19].
For example, an international survey of 18 national-level
guideline development programs (including Canada's
Cancer Care Ontario Practice Guidelines Initiative) found
most guideline development groups consisted of 10–20
members from three to five disciplines, and offered train-
ing in guideline development methodology to group
members. In addition, most of these groups based their
recommendations on systematic reviews of the research
evidence as well as formal or informal consensus proce-
dures when evidence was controversial or lacking [20].
Inconsistencies in CPG recommendations on the same
topic from different countries, however, are common, and
have been attributed to such factors as differing interpre-
tations of the research evidence, unsystematic guideline
development methods, and cultural differences between
health care systems [21]. In addition to the scientific evi-
dence, the guideline development process typically con-
siders other sources of evidence such as clinical
experience, patient preferences, resource implications and
feasibility [18,22]. The extent to which CPGs incorporate
research evidence also may vary according to such issues
as the perceived purpose of the guidelines, the resources
available to develop the guidelines, and the approach
used to generate group consensus on recommendations
[23]. The use of formal consensus-building strategies (e.g.,
the nominal group technique) is considered integral to
the quality of practice guidelines such as CPG's, consensus
statements and health technology assessments [18]. Much
remains to be known about the intricate decision-making
processes involved in the development of such clinical
practice policies. An investigation of the impact of small
group processes on the development of CPGs by multidis-
ciplinary teams revealed the influence of clear status hier-
archies, with higher-status professionals (e.g., medical
experts) contributing more to group discussions and deci-
sion-making than nurses or general practitioners [24,25].
Another recent ethnographic study of multi-disciplinary
guideline development groups [26] observed the entire
development process of two different CPGs, and identi-
fied distinct "repertoires of evaluation" used by group
members when developing their recommendations (e.g.,
robustness of the evidence, practicality in routine patient
care, political acceptability of the evidence). Moreira [26]
reported that group members altered their participation in
the decision-making process according to their comfort
with the particular evaluation mode predominant in the
group discussion, and that the resulting practice recom-
mendations represented combined knowledge from the
different "worlds" of science, practice, politics and proc-
ess.
The important question of when and how CPGs should
be modified and updated following their development
and dissemination has received considerably less atten-
tion, although such formal practice guidelines are
expected to be as evidence-based as feasible [19,27]. TheBMC Health Services Research 2008, 8:266 http://www.biomedcentral.com/1472-6963/8/266
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international survey of national guideline development
programs cited above found half did not have formal
update procedures [20]. An examination conducted in
2001 of the validity of all 17 CPGs developed by the US
Agency for Healthcare Research and Quality found almost
half the guidelines were obsolete within 5.8 years, leading
the authors to recommend that guidelines be reassessed
every three years as a general rule [28]. Although regularly-
scheduled literature updates have been recommended to
maintain CPG validity and minimize the burden of rigor-
ous systematic re-review [19,29], the resources and moti-
vations to do so may vary across different types of
guideline development groups (e.g., local vs. national).
Whereas standardized provincial prenatal records serve in
essence as clinical practice guidelines, their mandatory use
as part of the patient record and additional role in health
surveillance adds complexity to decision-making around
their content. However findings from the field of CPG
development and maintenance suggest that various issues
may influence decision-making around provincial prena-
tal content, such as the composition and dynamics of the
committee responsible for reviewing and updating the
prenatal records; the different sources and types of evi-
dence considered in the decision-making process; and sit-
uational factors such as time and resources allocated to
the review process.
The second topic, evidence-based health policymaking,
has been implicated in decision-making in health care.
Growing demand for a return from investments in health
services research has increased the need for transparency
and rationalization of health policy decision-making [4].
The term health policy is used variably in the evidence-
based decision-making literature to refer to broad politi-
cal actions taken by governments and other decision mak-
ers to improve the health of populations (e.g.,
regionalization of care), as well as more specific clinical
practice directives aimed at the population level (e.g.,
screening recommendations for breast cancer or other dis-
eases). Our study focus falls more closely within the latter
definition, which views evidence-based health policy (in
contrast to evidence-based clinical care) as the application
of best current knowledge to the health needs and values
of populations rather than individual patients [3].
To date, studies in the area of evidence-based health care
policymaking have focused largely on increasing research
uptake in the policy setting by means of strengthening
relationships between policy makers and researchers [30].
Few studies have directly examined how and under what
conditions research evidence is actually used to shape
health policy decision-making. Dobbins et al. [31] found
the strongest predictor of whether provincial public
health decision-makers used systematic reviews to influ-
ence their policy decisions was perceived organizational
value for the use of research evidence, and identified the
need to better understand how the organizational context
within public health units impacts on individual policy
decision-makers. A study of the use of evidence in the
development of local "health improvement programs" in
the UK found that decision-makers relied on a mix of
experiential (i.e., based on professional opinion and tacit
knowledge) and empirical (i.e., based on published
research or guidelines) evidence, and that national CPGs
were a particularly influential form of evidence in these
public health policy settings [1]. However this study also
revealed that public health decision makers considered
improving health, reducing health inequalities and
encouraging partnerships in the provision of care to be
more important goals than efficient provision of health
services, thus underscoring the role of political values in
shaping health policy decisions [1]. Black [32] also noted
that health care policymakers often have goals other than
maximizing clinical effectiveness, supporting the need to
further examine competing pressures within the decision-
making context. In contrast to individual patient care,
health care policies aimed at the population level must
address broader issues such as universal access, value for
money, and the needs/values of the population [3,4].
Practice recommendations that define clinical care for
entire populations, such as provincial prenatal records,
thus present a unique case study for evidence-based deci-
sion-making. Dobrow et al. [2] used the example of policy
development for colorectal cancer screening to demon-
strate how the decision-making context differs for evi-
dence-based decision-making at the individual clinician
level, as compared to health policy decision-making that
targets entire populations. Health care decisions at this
"population-policy level" affect more people, require
more explicit justification, and are influenced by a myriad
of competing issues (e.g., strength of the evidence, feasi-
bility of implementation, political attractiveness) [2,31].
Dobrow et al. defined "context" as all factors within an
environment where a decision is made and further distin-
guished between a modifiable "internal" context within
which the decision-making process occurs and a broader,
fixed, "external" decision-making context influencing
health policy decision outcomes. Criteria for universal
screening for a particular disease or risk factor also include
the availability of a valid screening test, acceptability of
routine screening to patients and health care providers,
evidence that the benefits of routine screening outweigh
potential harms, and demonstrated cost-effectiveness
[33,34], adding to the variety of evidence that may be
weighed to justify health policy decisions.
Findings from the field of evidence-based health policy
point to the decision-making environment at the provin-
cial level as an important influence on what types andBMC Health Services Research 2008, 8:266 http://www.biomedcentral.com/1472-6963/8/266
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sources of evidence are considered in decisions around
prenatal record content. An important gap that remains in
the literature is the relative influence of different types or
levels of contextual factors on the uptake and application
of evidence in health policy decision-making. By closely
examining how provincial prenatal records are reviewed
and revised, this study aims to identify key contextual
influences on evidence-based decision-making that can
help inform strategies to increase research uptake at the
population-policy level. The development of standard-
ized provincial prenatal records offers an intriguing exam-
ple of health policy decision-making, particularly as the
forms function as both national practice guidelines and as
a mandatory clinical documentation system. Prenatal
records also address a broad scope of clinical parameters,
allowing comparison of evidence integration across differ-
ent content areas. To more closely examine decision-mak-
ing processes within provincial prenatal record review
committees, this study will focus specifically on the
uptake and application of research evidence related to the
prenatal assessment of maternal smoking and alcohol use.
Prenatal assessment of maternal smoking and alcohol use
The Canadian Guide to Clinical Preventive Health Care
advocates routine prenatal screening and counseling for
the behavioral risk factors of both maternal smoking and
alcohol use [13]. According to the Public Health Agency of
Canada's 2005 Report on Maternal Child Health in Can-
ada, maternal smoking and alcohol consumption rates
have been decreasing but remain a public health concern
[35]. In 2003, 14% of recent mothers reported smoking
daily during pregnancy and about 14% also reported
drinking alcohol when pregnant [36].
Maternal smoking remains an important modifiable risk
factor for adverse perinatal outcomes as well as for as
longer-term mother and child health problems [37-39].
Health care costs attributable to smoking during preg-
nancy and postpartum are substantial, with low infant
birth weight carrying the highest economic burden
[40,41]. The implementation of clinical systems to sys-
tematically assess and document patient smoking status
has been shown to significantly increase the rate at which
clinicians intervene with patients who smoke [42]. More-
over, pregnancy is well-recognized as an opportune
"teachable moment" for smoking cessation due to
enhanced maternal motivation to quit and the strong
social stigma associated with smoking when pregnant
[43,44]. Best-practice guidelines for perinatal smoking
cessation and relapse prevention interventions based on
systematic reviews of the research evidence are widely
available in the literature (e.g., [45-49]), and Canada
boasts numerous national and provincial programs for
promoting smoking cessation during pregnancy as a result
of federal tobacco control initiatives in the early 1990's
[50]. Recommended strategies to reduce maternal smok-
ing derived from this body of research include screening
for tobacco use at each prenatal visit and using multiple
response formats to enhance disclosure; assessing pre-
pregnancy smoking history in addition to exposure to sec-
ond-hand tobacco smoke; and offering tobacco cessation
interventions to smoking women as well their smoking
partners.
Despite the availability of research evidence related to
effective screening and interventions to reduce maternal
smoking, current Canadian prenatal records vary mark-
edly in the extent to which they incorporate these best-
practice recommendations. A recent comparison of pro-
vincial and territorial prenatal records from all Canadian
provinces and territories found that all the prenatal record
forms included at least one question assessing maternal
tobacco use at the first prenatal visit, but only two of the
forms provided prompts for on-going monitoring of
maternal smoking throughout the rest of pregnancy and
only two included a prompt to refer smokers for special-
ized smoking cessation support [5]. Several of these pre-
natal records had been revised within the past few years,
suggesting that available research evidence related to
maternal smoking had somehow failed to penetrate the
prenatal record revision process.
The other behavioral risk factor of this study's interest is
maternal alcohol use. Alcohol use during pregnancy is a
significant and preventable public health issue that can
result in a lifelong burden of psychological, emotional,
and financial costs to the affected individuals and families
[51-53]. Prenatal exposure to alcohol is associated with a
continuum of effects including growth deficits, dysmor-
phology, and complex patterns of behavioral and cogni-
tive difficulties resulting from central nervous system
damage during fetal life [54]. High blood-alcohol concen-
tration is the most significant risk factor for fetal alcohol
spectrum disorders (FASD) and is related to timing of
exposure during fetal development, the pattern of con-
sumption of alcohol (e.g., binge drinking, that is four or
more drinks per occasion), and frequency of alcohol use
[55]. Guidelines developed by a subcommittee of the
Public Health Agency of Canada's National Advisory
Committee on FASD recommends that all pregnant and
post-partum women be screened for alcohol use [55]. A
comprehensive assessment of alcohol use during preg-
nancy is advocated to identify high risk drinking patterns,
discuss prenatal alcohol exposure and offer effective coun-
seling to decrease alcohol intake [56-58]. Of numerous
screening questionnaires that have been developed to
assess alcohol use, the brief, four-question T-ACE scale
has been determined as most accurate in detecting current
alcohol consumption, heavy alcohol use and risk drinking
among pregnant women [59]. A preliminary review ofBMC Health Services Research 2008, 8:266 http://www.biomedcentral.com/1472-6963/8/266
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maternal alcohol use questions on current Canadian pre-
natal records revealed that similar to the risk factor of
maternal smoking, provincial prenatal records vary con-
siderably in their screening questions and intervention
prompts related to maternal alcohol consumption. For
example, whereas four provinces/territories examined
include the T-ACE score in their prenatal record forms,
several others assess current maternal drinking status with
a simple yes/no question. In reviewing all of the provin-
cial and territorial forms, we noted some interesting par-
allels in the evidence-based content of smoking and
alcohol screening questions. With a few exceptions, those
provinces with weak questioning related to maternal
smoking were similarly weak regarding screening for alco-
hol use. This provides another indication that contextual
factors at the provincial level are influencing the use of
evidence in this example of population-policy decision-
making.
Conceptual Framework
This study of evidence-based decision-making by provin-
cial prenatal record review committees will be guided by
Dobrow et al.'s (2004) conceptual framework for "con-
text-based evidence-based decision-making" [2] (Figure
1). Dobrow et al. illustrated their model using an example
of health care decision-making at the "population-policy"
level (the development of a colorectal cancer screening
policy). According to this process-oriented model, both
internal and external contextual factors impact on what
individual sources of evidence are collectively weighed
and prioritized to justify decisions. The internal decision-
making context refers to the environment in which deci-
sions are made and includes the purpose of the decision-
making activity, participants' roles in the decision-making
process, and the strategies used to arrive at the decision
outcome (i.e., the specific questions around maternal
smoking and alcohol use to be included on the provincial
prenatal records). The individual participants on the pre-
natal record revision committees may influence the deci-
sion-making process through personal characteristics or
relationships they bring to the table, as demonstrated in
the previously-mentioned studies [23,24] of how small
group processes influence CPG development. The external
decision-making context refers to the provincial environ-
ment in which the decisions are applied, and involves
more fixed, uncontrollable factors such as patterns of serv-
ice delivery and dynamics among health professional
organizations; as well as economic, regulatory and other
sociopolitical features that may influence policy alterna-
tives. Dobrow et al.'s model traces how internal and exter-
nal contextual factors impact three main stages of
evidence utilization: 1) introduction of evidence, that is,
how evidence is identified and brought to the decision-
making table; 2) interpretation of evidence, which refers to
how the internal and external validity of the evidence is
evaluated; and 3) application of evidence (i.e., the ultimate
influence each individual source of evidence has on the
decision outcome).
This framework for evidence-based decision-making is
particularly useful for understanding why best-practice
recommendations related to maternal smoking and alco-
Conceptual framework for context-based evidence-based decision-making Figure 1
Conceptual framework for context-based evidence-based decision-making. Reprinted from Social Science and Medi-
cine, vol. 58, Dobrow M, Goel V, Upshur REG. Evidence-based health policy: Context and utilization, pp.207–17, copyright 
2004, with permission from Elsevier.
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hol consumption may have been differentially applied by
provincial prenatal record review committees, as it explic-
itly moves the focus of inquiry beyond "the evidence" to
specific contextual features within the broader policy
environment. Dobrow et al.'s model suggests numerous
propositions that may explain why some prenatal records
have more detailed and evidence-based questioning of
risk factors than others. For example, political pressure
from provincial medical associations to minimize govern-
ment control over medical practice (i.e., external decision-
making context) may act to decrease the number and spe-
cificity of prenatal record assessment questions and
prompts. Conversely, provinces with more time and
money allocated to the prenatal record revision process
and/or greater capacity of committee members to assess
the available research evidence (i.e., internal decision-
making context) would be expected to have more evi-
denced-base prenatal records. An important question to
address is how factors from both these different decision-
making contexts are collectively weighed to justify health
policy decisions. Because we are examining the integra-
tion of two areas of research evidence (maternal smoking
and alcohol use) in the prenatal record forms, our meth-
ods will allow us to decipher the relative influence of the
internal and external decision-making contexts both
within and across provincial prenatal record review com-
mittees, helping to identify key contextual factors influ-
encing decision-making at the population-policy level.
Methods
Design
A multiple case study with embedded units of analysis
will be used to examine and compare decision-making
processes within and across provincial prenatal record
review committees. The case study approach using mixed-
methods is most valuable when the questions being
posed require investigation of a real-life event in detail;
where the focus is on "how" and "why" questions; when
boundaries between phenomena and their context are not
clear; and when the investigators have little control over
events [60,61]. The diverse group of organizations and
individuals that work together to review and revise prena-
tal records within each Canadian province/territory offer
ideal natural "laboratories" for detailed analyses of popu-
lation-policy decision-making. Dobrow et al. [2] noted
the conceptual difficulty in distinguishing evidence from
context, and thus the case study design helps tease apart
their joint influence on decision-making. The multiple (or
"comparative") case study seeks both literal replication of
findings (obtaining the same results across similar cases)
and theoretical replication (obtaining different results but
for predictable reasons), allowing exploration of the
study's theoretical underpinnings [60]. Study cases are
carefully selected to pursue different patterns of theoreti-
cal replication; a larger number of cases (i.e., 6–10) pro-
vide more compelling support for predicted findings.
Guided by the framework for context-based evidence-
based decision-making, the overarching question for our
study is, "What is the influence of contextual factors on
the uptake and application of evidence by provincially-
mandated prenatal record review committees?" The main
unit of analysis for this case study is the prenatal record
revision process within each province/territory. To be able
to examine intricate decision-making processes in depth,
two sub-units of analysis (decisions around prenatal
record content pertaining to both maternal smoking and
alcohol use) will be embedded within each case study.
Ethical approval for this study has been granted by the
University of Ottawa Research Ethics Board and the affili-
ated research ethics boards from institutions of all the
study's co-principal and co-investigators [see Additional
file 1, Additional file 2, Additional file 3, Additional file 4
and Additional file 5].
Setting and Sample
We purposefully selected six Canadian provinces that var-
ied in the extent to which their prenatal record content
related to maternal smoking and alcohol use was evi-
dence-based, as reflected by questions and intervention
prompts included on current prenatal records from each
province and territory in Canada. We considered the
extent to which the prenatal forms integrated available
research evidence related to maternal smoking questions
as "weak" if the prenatal record simply inquired about
current smoking status, and "strong" if there were addi-
tional questions addressing issues such as previous smok-
ing history and exposure to environmental tobacco
smoke, and if the prenatal record provided for ongoing
monitoring and/or prompted referral of smokers to spe-
cialized smoking cessation resources. Similarly, we con-
sidered the extent to which prenatal record content related
to alcohol consumption was evidence-based to be "weak"
if questions simply inquired about present alcohol use,
and "strong" if the T-ACE scale also was included as part
of routine prenatal assessment. Of the six provinces cho-
sen for comparison, two had prenatal records with strong
screening questions for both smoking and alcohol use;
two had weak questioning related to both smoking and
alcohol use; one had strong smoking questions but
weaker alcohol-related questions; and one had weak
assessment of maternal smoking but stronger questions
related to alcohol use. The study's embedded design thus
allowed for the examination of 12 separate decision-mak-
ing events across these six provinces, in addition to com-
paring contextual influences on decision-making around
maternal smoking vs. alcohol use questions and prompts
within each of the case provinces. Other important dimen-
sions of comparison across the selected case provinces
may come to light as our case study unfolds, such as sizeBMC Health Services Research 2008, 8:266 http://www.biomedcentral.com/1472-6963/8/266
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of the province and type of organizational body responsi-
ble for maintaining the prenatal records.
Data Collection
Multiple sources of data will be used to explore internal
and external contextual factors at play during the prenatal
record revision process [60]. The principle sources of evi-
dence for this study will be in-depth interviews, survey
questionnaires, and document review. A case study proto-
col will be developed to ensure systematic and compara-
ble collection of data across different cases [60].
Preliminary telephone interviews will be conducted with
identified contacts within each of the selected case prov-
inces to obtain a basic profile of the province's prenatal
record review system, and to identify potential key
informants for in-depth interviews. A combination of pur-
posive and snowballing sampling will be used to obtain a
sample of key informants from each of the case study sites.
Informants may include (but are not limited to) the chair-
person as well as members of the provincial prenatal
record revision committee, clinical experts consulted by
the committee for the specific topics of maternal smoking
or alcohol use, policy makers in government responsible
for provincial maternal child health policies, and health
professional associations/colleges responsible for regula-
tory standards. Key informants will be interviewed in their
language of choice (English or French) either by tele-
phone or face-to-face during site visits to each case prov-
ince, using a semi-structured interview guide. Interviews
will address potential internal and external contextual fac-
tors as well as different types and sources of evidence that
may have contributed to decisions around prenatal record
content made during the province's most recent prenatal
record revision. These interviews will take approximately
one hour to complete. We anticipate interviewing an aver-
age of 12 key informants per case province. All interviews
will be audio-taped and transcribed verbatim. Following
the semi-structured interviews, participants will be asked
to complete demographic information and a survey ques-
tionnaire further exploring their perceptions of how deci-
sions around prenatal record content related to maternal
smoking and alcohol use were made. This theoretically
and empirically-based questionnaire will be reviewed by
an expert panel for face and content validity, refined, and
then piloted within two provinces not included as study
sites where the investigators have personal contacts with
prenatal record review committee members.
Pertinent documents (e.g., meeting agendas and minutes,
policy briefs, drafts of prenatal record revisions, published
studies or provincial guidelines used as reference materi-
als, lists of provincial committee members) will be exam-
ined (given organizational permission) during a site visit
to the provincial organizations responsible for the prena-
tal record review process in each of the six case provinces.
When permitted, documents and records will be copied to
include as part of the case study data base. The purpose of
the site visits are to interview key informants, collect addi-
tional corroborating documentary data, gain a first-hand
sense of the myriad actors and organizations involved in
the prenatal record review process, and seek potential
opportunities to directly observe decision-making proc-
esses in provinces currently engaged in prenatal record
review. Due to the large volume of data to be collected
and the variety of organizational settings that may need to
be visited per province, each site visit will be conducted by
the research associate accompanied by at least one of the
study investigators. Each site visit will be scheduled over
two days. Those conducting each site visit will be asked to
prepare a brief report including their field notes recording
their impressions and observations of the visit. This report
will be shared with provincial prenatal record committee
members to verify that we have provided an accurate
record of decision-making processes. The research associ-
ate will be responsible for organizing a case study data-
base for each case province, and for maintaining
additional field diaries throughout the study to record
observations and track events that may be of relevance to
findings and analysis.
Data Analysis
Transcription of interviews and data analysis will proceed
concurrently to permit follow-up of issues that might
emerge from the data. Data will be transcribed and ana-
lyzed in their source language (i.e., the language in which
the interviews were conducted). The content of interview
transcripts, documents and observations will first be ana-
lyzed descriptively to characterize the prenatal record
review process for each case province, and to develop a
detailed narrative of how and why decisions around pre-
natal record content related specifically to maternal smok-
ing and alcohol use were arrived at. The data will then be
examined using a number of qualitative data analysis
techniques and the analytic categories suggested by
Dobrow et al.'s conceptual model, while also building on
new insights that may arise from close familiarity with the
data. For example, content analysis of the data will be con-
ducted to identify different evidentiary sources weighed in
the decision-making process, as well as contextual features
of the decision-making environments. Contextual factors
will be coded and categorized according to their type (i.e.,
internal vs. external decision-making context) as well as
point of impact on individual sources of evidence (i.e.,
introduction, interpretation, or application of the evi-
dence). New or more refined categories may be developed
as needed. Data will be ordered and displayed using cate-
gory matrices, graphics and frequency tables [62]. The
analysis will be validated with key informants from the
participating provinces, to help generate a rich under-
standing of decision-making related to prenatal recordBMC Health Services Research 2008, 8:266 http://www.biomedcentral.com/1472-6963/8/266
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content within each case province. In the next phase, pat-
tern-matching [60] will be used to compare and contrast
decision-making processes both within each case province
(i.e., for maternal vs. alcohol prenatal record content) and
across the different case provinces. The mix of different
contextual factors as well as their effects on evidence utili-
zation will be tabulated using cross-site displays, to help
generate inferences about the relative impact of the deci-
sion-making environment on the prenatal record revision
process. Descriptive statistics will be used to analyze the
questionnaire results, and case sets will be compared
using non-parametric tests.
The four tests commonly used to ensure rigor in case study
designs are construct validity, internal reliability, external
validity and reliability [60]. Construct validity will be pur-
sued by using multiple sources of evidence, establishing a
chain of evidence, and having key informants review the
draft case study report for their province. Internal validity
will be addressed through pattern matching and seeking
rival explanations. Word tables will be generated inde-
pendently by investigators and where there are discrepan-
cies, discussions will ensue to reach consensus. External
validity will be strengthened through the use of multiple
cases to pursue replication of predicted findings, and reli-
ability will be pursued by developing and following a
comprehensive case study protocol, maintaining detailed
field notes and organizing a case study database [60].
Discussion
This study addresses an important gap in the field of evi-
dence-based decision-making by seeking to illustrate the
complex influence of contextual factors on decision-mak-
ing processes within provincial-level committees. It will
build on Dobrow et al.'s framework, generating knowl-
edge about specific contextual factors that maximize the
uptake of evidence in population-policy decision-making.
Specifically, this study will increase the transparency of
decision-making within provincial prenatal record com-
mittees and will thus help to identify effective strategies
for promoting the integration of research evidence into
the mandatory and widely used prenatal records. More
broadly, study findings will contribute to a model of evi-
dence-based decision-making that can be adapted to the
broader contextual features of policy environments, help-
ing inform avenues for promoting research utilization for
other types of committees developing provincial tools and
programs. Examples include the development of manda-
tory core program guidelines in Ontario (legislation that
requires health departments to provide stipulated pro-
grams and activities); and the development of surveillance
tools for use across clinical practice settings such as injury
surveillance, and patient safety monitoring tools.
Conclusion
This proposed research directly meets the Canadian Insti-
tutes of Health Research's knowledge translation strategic
direction of advancing research in the use of health-
related knowledge across the various levels of decision-
making in the health system. Therefore, the study results
should advance our understanding of internal and exter-
nal contextual factors that influence population-policy
decision-making. As such, results are expected to be of
interest to scientists working in the fields of knowledge
translation, public and population health, and health
services research.
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